Dr. Robert A. Langer, MD

Dr. Langer practices at P. James Voloshin M.D., Inc in Newport Beach, California.

Dr. Langer's NPI, 1093886046, was assigned on November 13, 2006. Dr. Langer graduated from New York University School of Medicine in 1976. Dr. Langer holds California license G43964.

Dr. Langer's primary practice is P. James Voloshin M.D., Inc, at 360 San Miguel Dr, Newport Beach, CA 92660 in Orange County. The practice phone is (949) 759-0995.

Dr. Langer's primary practice is P. James Voloshin M.D., Inc in Newport Beach, California. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Langer to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langer practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Langer's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Langer is board certified in dermatology by the American Board of Dermatology. Dr. Langer is licensed in California.

Dmand AI lists benign or precancerous skin growths, itchy rashes, skin cyst and skin discoloration among the conditions Dr. Langer treats.

CMS data shows 79 Medicare services from Dr. Langer across 3 procedure codes in 2024, for 51 Medicare patients. Medicare paid $4,968 for them. Every service was in an office.

CMS counts 51 Medicare patients who saw Dr. Langer in 2024. The largest group is 65 to 74, with 27 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Langer's median patient age at 64, with 46% women.

In 2024, Dr. Langer wrote 159 Medicare Part D claims for 80 patients. 91% of them were for generic drugs. CMS names the drug for 76 of them, across 5 drugs with 11 or more claims each, at $1,203 in total drug cost. In 2023, CMS named 110 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Langer for performance year 2024, reported as part of a group. Dr. Langer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 53 procedures of removal of skin lesions by Dr. Langer, more than 72% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 927 papers to Dr. Langer, published from 2001 to 2021. 2012 was the busiest year, with 38. The most frequent topics are Polymers, Biocompatible Materials and Drug Delivery Systems. Dr. Langer has published most often in Biomaterials. Dr. Langer's most frequent co-authors are Jeffrey M. Karp, MD, Omid C. Farokhzad, MD and Michael Honore Criqui, MD.

CMS Open Payments shows 93 general payments to Dr. Langer from 15 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $576.

Dmand AI lists 2 awards for Dr. Langer, most recently CMS Stage 1 2012 in 2011.

Dr. Langer graduated from New York University School of Medicine in 1976. Dr. Langer is a member of AAD.

Dr. Langer is in network with 12 carriers, including Aetna, United Healthcare and Humana. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.